HCPCS drug code · CMS crosswalk
Methotrexate Sodium J-Code / HCPCS Code
In short
Methotrexate Sodium is billed under HCPCS J9260 — Injection, methotrexate sodium, 50 mg. One billing unit is 50 mg. CMS's crosswalk lists 18 Methotrexate Sodium NDCs under this code.
Reference
- J9260
- Injection, methotrexate sodium, 50 mgBilling unit: 50 mg
- Labelers
- ACCORD HEALTHCARE INC; Accord Healthcare Inc; FreseniUS Kabi USA, LLC; Hikma Pharmaceuticals USA Inc.; Pfizer Inc; Teva Parenteral Medicines, Inc.
Medicare Part B payment limit
CMS ASP fileEffective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files
Methotrexate Sodium units and claim line
Enter the dose given to get the J9260 units and the NDC line for the CMS-1500 and the 837P.
Enter the dose given to build the claim line.
Methotrexate Sodium NDCs and billing units
From CMS’s ASP NDC–HCPCS crosswalk, effective October 1, 2026 through December 31, 2026. Billing units per package are CMS’s figures for the code’s unit.
| NDC (11-digit) | HCPCS | Labeler | Package | Billing units per package |
|---|---|---|---|---|
| 00143-9367-01 | J9260 | Hikma Pharmaceuticals USA Inc. | 1 | 20 |
| 00143-9519-10 | J9260 | Hikma Pharmaceuticals USA Inc. | 10 × 2 | 10 |
| 00143-9830-01 | J9260 | Hikma Pharmaceuticals USA Inc. | 1 | 20 |
| 00703-3671-01 | J9260 | Teva Parenteral Medicines, Inc. | 2 | 1 |
| 00703-3675-01 | J9260 | Teva Parenteral Medicines, Inc. | 10 | 5 |
| 00703-3678-01 | J9260 | Teva Parenteral Medicines, Inc. | 40 | 20 |
| 00703-3678-81 | J9260 | Teva Parenteral Medicines, Inc. | 40 | 20 |
| 16729-0277-03 | J9260 | ACCORD HEALTHCARE INC | 10 | 5 |
| 16729-0277-30 | J9260 | Accord Healthcare Inc | 2 | 1 |
| 16729-0277-35 | J9260 | Accord Healthcare Inc | 40 | 20 |
| 61703-0124-40 | J9260 | Pfizer Inc | 40 | 20 |
| 61703-0161-05 | J9260 | Pfizer Inc | 5 × 2 | 5 |
| 61703-0350-10 | J9260 | Pfizer Inc | 5 × 2 | 5 |
| 61703-0350-38 | J9260 | Pfizer Inc | 5 × 2 | 5 |
| 61703-0408-25 | J9260 | Pfizer Inc | 40 | 20 |
| 61703-0408-41 | J9260 | Pfizer Inc | 40 | 20 |
| 63323-0122-50 | J9260 | FreseniUS Kabi USA, LLC | 1 | 20 |
| 63323-0123-10 | J9260 | FreseniUS Kabi USA, LLC | 10 | 5 |
Methotrexate Sodium: common questions
- What is the J-code for Methotrexate Sodium?
- Methotrexate Sodium is billed under HCPCS J9260 — Injection, methotrexate sodium, 50 mg. One billing unit is 50 mg. CMS's crosswalk lists 18 Methotrexate Sodium NDCs under this code.
- How many J9260 billing units are in a package of Methotrexate Sodium?
- CMS lists 1 to 20 billing units per package, depending on the NDC, where one unit is 50 mg. Units to report are based on the dose given, not the package.
- Is J9260 a CPT code?
- No. J9260 is a HCPCS Level II code from CMS for the drug itself. Giving it, for example by injection or infusion, is usually reported with a separate CPT administration code.